The Francis Crick Institute: Discovery without boundaries




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: The Francis Crick Institute: Discovery without boundaries
Released on: July 08, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Dr David Roblin (keynote speaker at the 2016 On Helix conference and Chief Operating Officer and Director of Scientific Translation at The Francis Crick Institute) discusses the soon-to-be opened Francis Crick Institute; a centre set up specifically to help develop ground breaking science.
  • Summary
  • Transcript
  • Participants
  • Company
Dr David Roblin (keynote speaker at the 2016 On Helix conference and Chief Operating Officer and Director of Scientific Translation at The Francis Crick Institute) discusses the soon-to-be opened Francis Crick Institute; a centre set up specifically to help develop ground breaking science. Once fully operational, the Francis Crick Institute will employ 1500 staff, including 1250 scientists, and have an operating budget of approximately £130 million a year.
Dr David Roblin (keynote speaker at the 2016 On Helix conference and Chief Operating Officer and Director of Scientific Translation at The Francis Crick Institute) discusses the soon-to-be opened Francis Crick Institute; a centre set up specifically to help develop ground breaking science. Once fully operational, the Francis Crick Institute will employ 1500 staff, including 1250 scientists, and have an operating budget of approximately £130 million a year.
David Roblin joined the Crick in September 2014. As well as taking on the role of COO, David also leads translational activities for the Crick as it accelerates its science for health and wealth benefits. David practised medicine for five years before entering the pharmaceutical industry. He has held significant leadership roles in his pharmaceutical career, with general management, research, development and commercial responsibilities. He was formerly Senior Vice President, Head of Research, for Pfizer's European R&D. Since he left Pfizer in early 2011, David has been Chief Medical Officer and a Non-Executive Director to a number of biotech companies. He also serves on the Major Awards Committee of the Biomedical Catalyst Fund and on Confidence in Concept and Proximity to Discovery of Medical Research Council as well as the LEO Foundation Prize Committee. David has a degree in biochemistry from University College London and later qualified in medicine from St George's Hospital. He is a Fellow of the Royal College of Physicians and a member of the Faculty of Pharmaceutical Medicine. He is an honorary Professor of Medicine at Swansea University and Professor of Translational Medicine at St George's. He is a Board Director of MedCity.
The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the scientific mechanisms of living things. Its work is helping to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. By bringing together scientists from many disciplines, the Crick will help to improve people's lives and keep the UK at the forefront of innovation in medical research, attracting high-value investment and strengthening the economy. The Francis Crick Institute is a consortium of six of the UK's most successful scientific and academic organisations - the Medical Research Council (MRC), Cancer Research UK (CRUK), the Wellcome Trust, UCL (University College London), Imperial College London and King's College London. By combining specialist knowledge, expertise and resources from each of these organisations, the Francis Crick Institute undertakes ground-breaking research across a range of scientific disciplines and helps laboratory discoveries to be turned into treatments as quickly as possible. The Francis Crick Institute is a registered charity. Overall responsibility for setting the strategic direction of the institute lies with its Board. An Executive Management Team led by Sir Paul Nurse is responsible for leading the organisation and implementing its scientific vision and research strategy. The organisations in the consortium have invested a total of around £650 million to establish the institute and to ensure that it is resourced to make a major impact. The MRC's National Institute for Medical Research and CRUK's London Research Institute (at Lincoln's Inn Fields and Clare Hall) became part of the Francis Crick Institute on 1 April 2015 but will remain at their existing locations until they move into the new laboratory building at St Pancras in 2016. When it is fully operational, the Francis Crick Institute will employ 1500 staff, including 1250 scientists, and have an operating budget of approximately £130 million a year.